110 related articles for article (PubMed ID: 37167706)
41. BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health.
Tran HT; Wan MLY; Ambite I; Cavalera M; Grossi M; Háček J; Esmaeili P; Carneiro ANBM; Chaudhuri A; Ahmadi S; Svanborg C
Sci Rep; 2024 Feb; 14(1):3838. PubMed ID: 38360830
[TBL] [Abstract][Full Text] [Related]
42. Alpha-lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human alpha-lactalbumin made lethal to tumor cells).
Svensson M; Fast J; Mossberg AK; Düringer C; Gustafsson L; Hallgren O; Brooks CL; Berliner L; Linse S; Svanborg C
Protein Sci; 2003 Dec; 12(12):2794-804. PubMed ID: 14627739
[TBL] [Abstract][Full Text] [Related]
43. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
44. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
[TBL] [Abstract][Full Text] [Related]
45. Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy.
Pei W; Cai L; Gong X; Zhang L; Zhang J; Zhu P; Jiang H; Wang C; Wang S; Chen J
Mater Today Bio; 2022 Jun; 15():100272. PubMed ID: 35607417
[TBL] [Abstract][Full Text] [Related]
46. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
Rowehl RA; Burke S; Bialkowska AB; Pettet DW; Rowehl L; Li E; Antoniou E; Zhang Y; Bergamaschi R; Shroyer KR; Ojima I; Botchkina GI
PLoS One; 2014; 9(6):e99091. PubMed ID: 24921652
[TBL] [Abstract][Full Text] [Related]
47. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
Hongdan L; Feng L
Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
[TBL] [Abstract][Full Text] [Related]
48. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
49. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
[TBL] [Abstract][Full Text] [Related]
50. DEAD box protein DDX1 promotes colorectal tumorigenesis through transcriptional activation of the LGR5 gene.
Tanaka K; Ikeda N; Miyashita K; Nuriya H; Hara T
Cancer Sci; 2018 Aug; 109(8):2479-2489. PubMed ID: 29869821
[TBL] [Abstract][Full Text] [Related]
51. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
[TBL] [Abstract][Full Text] [Related]
52. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
[TBL] [Abstract][Full Text] [Related]
53. Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells.
Morgan RG; Molnár E; Jones RF; Collard TJ; Lane JD; Greenhough A; Paraskeva C; Williams AC
Br J Cancer; 2015 Feb; 112(4):714-9. PubMed ID: 25611300
[TBL] [Abstract][Full Text] [Related]
54. A Positive Tetraspanin 8 (TSPAN8)/β-Catenin Regulatory Loop Enhances the Stemness of Colorectal Cancer Cells.
Zhan Z; Zhong L; Feng M; Guo Y
Med Sci Monit; 2019 Dec; 25():9594-9601. PubMed ID: 31838484
[TBL] [Abstract][Full Text] [Related]
55. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q
Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004
[TBL] [Abstract][Full Text] [Related]
56. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
57. Oleic acid complex of bovine α-lactalbumin induces eryptosis in human and other erythrocytes by a Ca(2+)-independent mechanism.
Hoque M; Nanduri R; Gupta J; Mahajan S; Gupta P; Saleemuddin M
Biochim Biophys Acta; 2015 Sep; 1850(9):1729-39. PubMed ID: 25913522
[TBL] [Abstract][Full Text] [Related]
58. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
[TBL] [Abstract][Full Text] [Related]
59. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
60. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
